美股市场个股详情

MIST Milestone Pharmaceuticals

添加自选

1.740
-0.010-0.57%

收盘价 05/17 16:00 (美东)

1.720
-0.020-1.13%

盘后 17:20 (美东)

9267.32万总市值-1392市盈率TTM

Milestone Pharmaceuticals股票讨论区

登录发表评论

Jaguar8

05/02 07:01

$Milestone Pharmaceuticals(MIST.US)$
NEWS
Milestone® Pharmaceuticals Announces Data Presentations on Etripamil at Heart Rhythm 2024, 2024 Stanford BioDesign Arrhythmia Technologies Retreat, and ISPOR 2024

JCBF

01/28 21:16

$Milestone Pharmaceuticals(MIST.US)$ 👀👀

夜轻歌

01/02 08:33

$Milestone Pharmaceuticals(MIST.US)$ 创新低了继续观察一下

Moomoo AI

2023/12/30 07:59

Despite significant insider shares, Milestone Pharmaceuticals noted fairly low insider ownership. The absence of recent insider transactions is raising concerns. It's more encouraging if insiders bought more shares in the company.

Milestone Pharmaceuticals Insiders Lose Out As Stock Sinks To US$1.67

Moomoo Recap US

2023/12/26 15:59

专栏Wall Street Today | S&P 500 Inches Closer to Record High

RECAP
S&P 500 Approaches All-Time High
US stocks rose, with the $标普500指数(.SPX.US)$ approaching its all-time, high as optimism over potential interest rate cuts next year continued to fuel positive sentiment on the last trading week of the year.
The S&P 500 closed 0.42% higher at 4,774.75 on the first day of the holiday-shortened trading week. The $纳斯达克综合指数(.IXIC.US)$ gained 0.5% to 15,074.57, while the $道琼斯指数(.DJI.US)$ added 0.4...

12月FOMC纪要：24年或降息，但路径高度不明

Trytosaveabit

2023/12/26 06:54

FDA ANSWER! Yuck! Hehehe

$Milestone Pharmaceuticals(MIST.US)$ Milestone Pharmaceuticals Received An FDA Refusal To File Letter For The New Drug Application For Self-administered Etripamil Nasal Spray For Paroxysmal Supraventricular Tachycardia

Trytosaveabit

2023/10/24 06:10

Watching

$Milestone Pharmaceuticals(MIST.US)$ Milestone Pharmaceuticals Reports Submission Of New Drug Application To FDA For Etripamil

Analysts Notebook

2023/06/20 07:06

专栏US Top Rating Updates on 6/20: BIDU, PM, PFGC, PGR and MORE

$前进保险(PGR.US)$ initiated at equal-weight by Morgan Stanley, announced target price at $135.00.
$Lemonade(LMND.US)$ initiated at underweight by Morgan Stanley, announced targe price at $14.00.
$百度(BIDU.US)$ was upgraded by Morgan Stanley from equal-weight to overweight, increased target price from $160.00 to $190.00.
$菲利普莫里斯(PM.US)$ was upgraded by Citigroup from neutral to buy, increased target price from $10...

BioPharm Insight US

2022/11/07 10:19

专栏Weekly FDA Drug Pipeline Calendar (Nov 7 - Nov 11)

Hello mooers, welcome to another week of the FDA calendar. Here are what happened last week and what's coming up this week.
Top Medical News of the Week
Lab-grown blood given to humans in world-first trial aimed at combatting rare disorders
Blood grown in a laboratory has been transfused into humans for the first time in a landmark clinical trial that U.K. researchers say could significantly improve treatment for people with blood disorders and r...

Moomoo Breakfast US

2022/05/02 07:19

专栏Today's pre-market stock movers: JELD, BILI, NIO, XPEV and more

Gainers：
• $Innoviz Technologies(INVZ.US)$ +18.7% (selected by "large automotive group manufacturer" to become its direct LiDAR supplier across multiple brands)
• $希尔托普控股(HTH.US)$ +15.7% (commenced a modified "Dutch auction" tender offer to purchase for cash up to $400 mln of its common stock at a price per share not less than $28,00 and not greater than $32.00 less any applicable withholding taxes and without interest usin...

暂无评论

分析

分析师评级

暂无数据

目标价预测

暂无数据

热议

美股

综合热度